Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 10
1996 20
1997 23
1998 19
1999 16
2000 7
2001 13
2002 21
2003 7
2004 11
2005 20
2006 19
2007 12
2008 15
2009 21
2010 28
2011 23
2012 14
2013 23
2014 11
2015 17
2016 16
2017 6
2018 7
2019 27
2020 24
2021 17
2022 14
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Results by year

Filters applied: . Clear all
Page 1
Antineoplastic Effects of Ankaferd Hemostat.
Malkan UY, Haznedaroglu IC. Malkan UY, et al. Among authors: haznedaroglu ic. Biomed Res Int. 2022 Aug 2;2022:2665903. doi: 10.1155/2022/2665903. eCollection 2022. Biomed Res Int. 2022. PMID: 35958818 Free PMC article. Review.
Ankaferd hemostat: from molecules to medicine.
Çiftçiler R, Haznedaroglu İC. Çiftçiler R, et al. Among authors: haznedaroglu ic. Turk J Med Sci. 2020 Nov 3;50(SI-2):1739-1750. doi: 10.3906/sag-1908-161. Turk J Med Sci. 2020. PMID: 32283900 Free PMC article. Review.
Covid-19 scientific publications from Turkey.
Çiftçiler R, Haznedaroğlu İC, Tufan A, Öztürk MA. Çiftçiler R, et al. Among authors: haznedaroglu ic. Turk J Med Sci. 2021 Jun 28;51(3). doi: 10.3906/sag-2010-261. Turk J Med Sci. 2021. PMID: 33306333 Free article. Review.
Protein Kinases in Hematological Disorders.
Okay M, Haznedaroglu IC. Okay M, et al. Among authors: haznedaroglu ic. Adv Exp Med Biol. 2021;1275:383-393. doi: 10.1007/978-3-030-49844-3_15. Adv Exp Med Biol. 2021. PMID: 33539024 Review.
Perspectives for immune plasma treatment of COVID-19.
Sayinalp B, Çinar OE, Haznedaroğlu İC. Sayinalp B, et al. Among authors: haznedaroglu ic. Turk J Med Sci. 2021 Feb 26;51(1):1-9. doi: 10.3906/sag-2005-410. Turk J Med Sci. 2021. PMID: 32718128 Free PMC article. Review.
Review on Characteristics and Analytical Methods of Rivaroxaban.
Reçber T, Haznedaroğlu İC, Çelebier M. Reçber T, et al. Among authors: haznedaroglu ic. Crit Rev Anal Chem. 2022;52(4):865-877. doi: 10.1080/10408347.2020.1839735. Epub 2020 Nov 4. Crit Rev Anal Chem. 2022. PMID: 33146024 Review.
Ruxolitinib for myelofibrosis.
Haznedaroglu IC. Haznedaroglu IC. N Engl J Med. 2012 May 24;366(21):2032; author reply 2032-5. doi: 10.1056/NEJMc1203704. N Engl J Med. 2012. PMID: 22621635 No abstract available.
Hematological aspects of the COVID-19 syndrome.
Malkan UY, Haznedaroglu IC. Malkan UY, et al. Among authors: haznedaroglu ic. Eur Rev Med Pharmacol Sci. 2022 Jun;26(12):4463-4476. doi: 10.26355/eurrev_202206_29086. Eur Rev Med Pharmacol Sci. 2022. PMID: 35776048 Free article.
420 results